Himadri Speciality Chemical Recommends Final Dividend of ₹0.80 per Share for FY26
Himadri Speciality Chemical's Board has recommended a final dividend of ₹0.80 per equity share for FY25-26. This is subject to shareholder approval at the ensuing AGM. The dividend, if approved, will be paid within 30 days of declaration.
Dividend recommendations generally have a positive but moderate impact on the stock price, reflecting a return of profits to shareholders.
The recommendation of a final dividend is a positive indicator for shareholders.
Himadri Speciality Chemical Limited announced that its Board of Directors, in a meeting held on April 23, 2026, has recommended a final dividend of ₹0.80 per equity share of ₹1 each (80% of face value). This recommendation is subject to the approval of the shareholders at the upcoming Annual General Meeting (AGM).
If declared by the shareholders at the AGM, the dividend will be paid within 30 days from the date of declaration. The record date for determining the entitlement of members to this final dividend will be intimated in due course.
The Board of Directors' meeting commenced at 12:00 p.m. (IST) and concluded at 4:00 p.m. (IST) on April 23, 2026. The company will also make this information available on its website, www.himadri.com.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.